At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,008 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Stryker Neurovascular Trevo® Retriever Registry
In Brief
An observational study for Ischemic Stroke. Completed, enrolled 2,008 participants across 80 sites in 12 countries.
Detailed Summary
The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Stroke
CountriesCanada, Czechia, France, Germany, Hungary, Italy, Singapore, South Korea, Spain, Switzerland, Thailand, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedJan 2014
Primary CompletionDec 2017
TodayJul 2026
First PostedJan 20, 2014
Enrollment StartNov 25, 2013
Primary CompletionDec 28, 2017
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 12.5 years ago